Vice President

• The Global Program Lead (GPL) serves as the “point of accountability” for one or more assets.
• The GPL role is accountable for leading the Global Program Team and orchestrating the design and execution of a global integrated program strategy from candidate nomination through drug development to successful launch and commercialization.
• Develops and manages product strategy and late drug development program to ensure approval and commercial success.
• Defines and executes the strategic integrated development plan (IDP) in partnership with the cross functional GPT members.
• Participates in regulatory filings (NDA, BLA filings) as well as develops strategy for orphan drug designation.
• Engages with Health Authorities and/or Advisory Committees.
• Leads team to develop program strategy and clinical program, commercialization strategy plans, business case development, and understands how access, pricing and reimbursement needs for supporting value proposition will inform trial design.
• Builds and maintains collaborative relationships with external stakeholders (Opinion Leaders, Strategic Alliance Partners, Patient Advocacy Leaders, Health Authorities) and appropriately incorporates insights and advice to maximize program impact.
• Actively supports Investor Relations and Public Affairs in managing external BMS communications.
• Integrates commercialization inputs and deliverables to design the late program strategy that enables approval of a meaningfully differentiated asset with potential to maximize asset value.

Vice President, Global Program Lead – Neuroscience

VP, Securities Based Lending

VP, Customer

Vice President – Emerging Technologies

Vice President, Macroeconomic Model Development, Scenario Expansion

AVP, Technical Manager